A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer prevention

BACKGROUND: Identifying female carriers of BRCA1 and BRCA2 mutations is imperative for prevention of ovarian cancer and breast cancer. There are five major histologic subtypes of ovarian cancer and high grade serous cancer (the most common) is reported in 75–100% of BRCA1 and BRCA2 mutation carriers...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanley, Gillian E., McAlpine, Jessica N., Miller, Dianne, Huntsman, David, Schrader, Kasmintan A., Blake Gilks, C., Mitchell, Gillian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838948/
https://www.ncbi.nlm.nih.gov/pubmed/29506471
http://dx.doi.org/10.1186/s12885-018-4153-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838948/
https://www.ncbi.nlm.nih.gov/pubmed/29506471
http://dx.doi.org/10.1186/s12885-018-4153-8

Ejemplares similares